CORD-19:e847d433e7424152a9846673209cb73027415ecd / 274291-274765 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2586","span":{"begin":0,"end":474},"obj":"Sentence"},{"id":"T3992","span":{"begin":0,"end":474},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, a newly developed phagocytosis assay based on flow cytometry (flow assay) was using sera obtained from rabbit postvaccination with a bivalent conjugate of Neisseria meningitidis serogroup A capsular polysaccharide (CPSA) to serogroup B outer membrane vesicle containing PorA (OMV-PorA), an OMV-PorA of Neisseria meningitidis serogroup B and the CPSA (as control), was done in order to evaluation of the potential efficacy of (experimental) meningococcal vaccines."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T299","span":{"begin":0,"end":474},"obj":"Sentence"}],"text":"Therefore, a newly developed phagocytosis assay based on flow cytometry (flow assay) was using sera obtained from rabbit postvaccination with a bivalent conjugate of Neisseria meningitidis serogroup A capsular polysaccharide (CPSA) to serogroup B outer membrane vesicle containing PorA (OMV-PorA), an OMV-PorA of Neisseria meningitidis serogroup B and the CPSA (as control), was done in order to evaluation of the potential efficacy of (experimental) meningococcal vaccines."}